Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Allergan plc (AGN)

166.08   0.23 (0.14%) 07-15 16:00
Open: 165.63 Pre. Close: 165.85
High: 167.21 Low: 165.1601
Volume: 5,729,184 Market Cap: 54445M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 167.294 - 168.118 168.118 - 168.954
Low: 163.2 - 164.064 164.064 - 164.94
Close: 164.702 - 166.06 166.06 - 167.437

Technical analysis

as of: 2019-07-15 4:40:06 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 198.78     One year: 232.18
Support: Support1: 135.63    Support2: 114.27
Resistance: Resistance1: 170.19    Resistance2: 198.78
Pivot: 163.99
Moving Average: MA(5): 166.21     MA(20): 154.30
MA(100): 143.03     MA(250): 157.60
MACD: MACD(12,26): 9.06     Signal(9): 8.77
Stochastic oscillator: %K(14,3): 90.05     %D(3): 90.97
RSI: RSI(14): 71.10
52-week: High: 197.00  Low: 114.27  Change(%): -5.5
Average Vol(K): 3-Month: 411484  10-Days: 511915

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
AGN has closed below upper band by 44.4%. Bollinger Bands are 71.1% wider than normal. The large width of the bands suggest high volatility as compared to AGN's normal range. The bands have been in this wide range for 13 bars. This is a sign that the current trend might continue.

Headline News

Sun, 14 Jul 2019 19:08:30 Z
Is Allergan a Buy?

Sat, 13 Jul 2019 13:07:38 Z
Better Buy: AbbVie vs. Merck

Thu, 11 Jul 2019 14:21:20 Z
J&J (JNJ) to Kick-Start Pharma Q2 Earnings: A Beat in Store?

Thu, 11 Jul 2019 00:08:55 Z
Allergan (AGN) Gains But Lags Market: What You Should Know

Wed, 10 Jul 2019 14:12:57 Z
Will Patent Woes Boost Pharma Stock Megamergers Further?

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 327.80
Shares Float (M) 326.95
% Held by Insiders 0.30
% Held by Institutions 88.91
Shares Short (K) 5340
Shares Short P. Month (K)

Stock Financials

EPS -21.460
EPS Est. Current Year 16.210
EPS Est. Next Year 16.890
EPS Est. Next Quarter 4.770
Forward EPS 16.515
Book Value (p.s.) 187.740
PEG Ratio 3.29
Profit Margin -45.94
Operating Margin 3.97
Return on Assets (ttm) 0.4
Return on Equity (ttm) -10.8
Qtrly Rev. Growth -2.0
Gross Profit (p.s.) 41.245
Sales Per Share
EBITDA (p.s.) 21.538
Qtrly Earnings Growth
Operating Cash Flow (M) 5420.00
Levered Free Cash Flow (M) 5680.00

Stock Valuations

P/E -7.74
P/E Growth Ratio
P/BV 0.88
P/S 1165511168.00
P/CF 10.04

Dividends & Splits

Dividend 2.900
Dividend Yield 0.02
Dividend Pay Date 2019-06-14
Ex-Dividend Date 2019-05-13
Forward Dividend 2.960
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.